Objective To evaluate the clinical value of prenatal array comparative genomic hybridisation (CGH) in screening for submicroscopic genomic imbalances. ;Design Cross-sectional study. ;Setting Tertiary referral centre. ;Population From June 2008 to February 2011, 3171 fetuses underwent prenatal array CGH testing and karyotyping at the National Taiwan University Hospital. Indications for invasive prenatal diagnosis included abnormal karyotype, abnormal ultrasound, advanced maternal age and parental anxiety. ;Methods In all, 2497 fetuses were screened with 1-Mb resolution bacterial artificial chromosome array-based CGH, and 674 fetuses with 60-K oligonucleotide array-based CGH. Multiplex ligationdependent probe amplification, fluorescence in si...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Background: Current pathways for testing fetuses at increased risk of a chromosomal anomaly because ...
The mainstay for prenatal diagnosis of fetuses with abnormal ultrasound is karyotyping. Array compar...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
OBJECTIVE: To evaluate the effectiveness of whole-genome array comparative genomic hybridization (aC...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Microarray-based comparative genomic hybridization (array CGH) is a newly emerged molecular cytogene...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Objectives: Array comparative genomic hybridization (CGH) has become the technology of choice for hi...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Background: Current pathways for testing fetuses at increased risk of a chromosomal anomaly because ...
The mainstay for prenatal diagnosis of fetuses with abnormal ultrasound is karyotyping. Array compar...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
Objective: This study aims to evaluate the diagnostic yield of comparative genomic hybridization mic...
OBJECTIVE: To evaluate the effectiveness of whole-genome array comparative genomic hybridization (aC...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Microarray-based comparative genomic hybridization (array CGH) is a newly emerged molecular cytogene...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Objectives: Array comparative genomic hybridization (CGH) has become the technology of choice for hi...
To assess the feasibility of offering array-based comparative genomic hybridization testing for pren...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Conventional karyotyping detects chromosomal anomalies in up to 35% of pregnancies with fetal ultras...
Background: Current pathways for testing fetuses at increased risk of a chromosomal anomaly because ...